Ch∆llenging the Impossible
See what makes us who we are
Avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.
We believe a difference in our products, combined with a difference in how we work, communicate and partner, can change the entire world.
We are committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.
We develop, manufacture and market recognized brands in more than 90 countries.
Rooted in Care
We are active with our customers and consider their needs in all directions
We value results over activities
We work seamlessly across functions
We are straightforward, honest, and respectful
We use time as a key measure
We keep a worldwide perspective on customers and employees
Leading Us Forward
Prior to joining the company in 2017, Joe served as chief executive officer and president of Acelity, where he was responsible for overseeing the development and commercialization of their innovative wound care and regenerative medicine business. He also served as global president, vascular therapies, for Covidien, creating their vascular division and leading the company’s acquisition and integration of ev3.
Before his time at Covidien, Joe served as Smith & Nephew’s global president, advanced wound management, and Alliance Imaging’s vice president, Pacific operations. He previously served as board director for Acelity, the Advanced Medical Technology Association (AdvaMed) and Systagenix Wound Management. He also served as Chair of AdvaMed’s Wound Healing and Tissue Regeneration Sector.
He holds a bachelor’s degree from California State University, Fullerton.
His significant operations and R&D leadership experience includes more than 30 years in a variety of manufacturing, service, engineering, and quality positions within GE Healthcare, GE Transportation Systems, Hill-Rom, as well as Harris Corp’s Communications and Aerospace Systems divisions.
Prior to joining the company, Dave served as Senior Vice President of Operations for Acelity, where he led the company’s global manufacturing operations and oversaw its inventory, supply chain, procurement and facilities functions. In that role, he was instrumental in optimizing Acelity’s cost structure and sustaining the savings throughout the company’s expansion.
Dave earned bachelor’s and master’s degrees in electrical engineering from the Georgia Institute of Technology.
Lee has more than 25 years of medical device design and development experience. Prior to joining the company, he successfully led numerous R&D organizations at Covidien and built PMO and technology development organizations. Most recently, he was the vice president of R&D for the venous solutions franchise of Peripheral Vascular at Covidien. Under his leadership, teams have developed and brought to market more than 40 innovative solutions. Lee currently holds 10 US patents and has a number of additional patents pending.
He earned a bachelor’s degree in plastics engineering from the University of Massachusetts at Lowell and a master’s of business administration from the University of Massachusetts at Amherst.
Lee is an active member of the Southeastern Medical Device Association (SEMDA) board.
Rhonda’s background includes numerous leadership roles in human resources, operations and sales. She joined the company in 2014 following the spinoff from Kimberly-Clark, which she joined in 2005. She held positions including vice president – Talent Management, Organizational Effectiveness and Diversity, as well vice president – Human Resources and Organizational Effectiveness. Prior to accepting her current role, Rhonda was vice president, Global Human Resources and Global Labor Relations. She was responsible for managing human capital strategy and ensuring the robust leadership succession for global business units and labor relations.
Rhonda holds a bachelor’s degree in management from Southern Wesleyan University and a master’s degree in human resource development and business administration from Clemson University.
She serves on the Health Businesswomen’s Association’s Advisory Board and Mission Joint Venture International.
Michael joined the company in 2020, bringing more than 20 years of corporate finance, accounting, treasury and M&A strategy experience in a variety of industries including medical devices, pharmaceuticals and biotech. He also has a proven track record in change management and shareholder value creation.
Prior to joining the company, Michael served as Executive Vice President and CFO for AngioDynamics, Inc., a publicly listed healthcare company, where he played an integral role in transforming its portfolio through both internal development and M&A. Prior to that, he was the CFO at Extreme Reach, Inc.
Michael holds both a bachelor’s and master’s degree in accounting from Fairleigh Dickinson University and a master’s of business administration degree from Columbia University. He is a Certified Public Accountant.
Mizanu’s vast experience includes more than 20 years in the medical devices, pharmaceutical and health care industries. He joined the company in 2013 as vice president, global quality, before accepting his current role. Prior to joining the company, he held senior level positions at Johnson & Johnson and Steris Corporation.
He earned a bachelor’s degree in medical technology and a master’s degree in microbiology and immunology from Murray State University. He is also a certified Process Excellence Six Sigma Black Belt, has been published in numerous scientific journals and received a number of patents in medical device areas.
Mizanu serves as an Advisory Board Member for United Way, North Fulton and is actively involved with United Way of Greater Atlanta.
Prior to his current role with the company, Warren spent more than 25 years at Kimberly-Clark, primarily in Finance. As senior director of HealthCare Strategy for Kimberly-Clark, Warren led the successful HealthCare spinoff in 2014. Additionally, he led business integrations of more than five transactions which resulted in a threefold increase of the Health Care segment revenue. He also held numerous leadership positions in Strategy, Sales and Marketing across the company’s HealthCare, Professional and Consumer divisions.
Warren has been instrumental in leading corporate transactions totaling more than $3 billion in value, including the spin from Kimberly-Clark, the divestiture of the S&IP segment and several acquisitions.
He holds a bachelor’s degree in finance from Indiana University.
Arjun joined the company in 2017 as vice president and general manager of the company’s Asia-Pacific business. With a background in finance, he has a proven track-record of driving growth and business performance, as well as building high-performing teams.
Prior to joining the company, Arjun spent 10 years at Covidien/Medtronic where he held roles in general management and finance. He also worked for Honeywell in its specialty materials portfolio. Additionally, he spent seven years with a British distribution group and four years with a public accounting firm in London.
Arjun is a chartered accountant from the Institute of Chartered Accountants in England and Wales. He earned a bachelor’s degree from Delhi University in New Delhi, India as well as a degree in accounting from Oxford-Brookes University, UK.
He is a former member of the advisory board of CFO Asia magazine, a regular panelist at Economist CFO roundtables and was co-chairman of the Medical Devices committee in AMCHAM India.
John joined the company in 2014 following the spinoff from Kimberly-Clark. Prior to that, he was Kimberly-Clark’s vice president, deputy general counsel and corporate secretary, overseeing corporate transactions, SEC compliance, corporate finance, government relations, and corporate governance matters. John joined Kimberly-Clark in 2000 and served in various legal roles of increasing responsibility. Before joining Kimberly-Clark, he was a partner at the Dallas law firm of Carrington, Coleman, Sloman & Blumenthal LLP, specializing in corporate, securities, financial, M&A and general commercial and business law.
He holds a bachelor’s degree in political science from the University of Minnesota and a Juris Doctor from the Marshall-Wythe School of Law, College of William and Mary.
Michael has more than 30 years of experience in the medical device industry with significant experience in commercial execution of new products, acquisitions and sales and marketing resource deployment. He spent the first 23 years of his career with Johnson & Johnson (Ethicon Inc., Ethicon EES, JJHCS and Biosense Webster) in increasing levels of commercialization leadership roles. Michael led North America sales and marketing for Carefusion’s Respiratory division. Additionally, he served in key leadership roles for two different startup companies.
Michael has a bachelor’s degree in business administration from The University of Redlands, California, and a master’s degree in business administration from Pepperdine University.
Kerr has more than 25 years of experience in the medical device and pharma/biotech industries, including extensive experience driving global growth via new product development, M&A and commercial execution. He started his career in sales and sales management with Eli Lilly & Company and led marketing and business development functions for McKesson Corporation. Prior to joining Avanos, Kerr held positions in marketing, business development and general management with Covidien’s $6B Minimally Invasive Therapies Group (now part of Medtronic), and as Chief Commercial Officer with AlloSource, a $300M regenerative medicine company focused on sports, spine and orthopedic applications.
Kerr has a bachelor’s degree in business from The University of Kansas and a master’s degree in business administration from the Kellogg Graduate School of Management at Northwestern University.
Tom’s experience in the medical device industry includes more than 25 years focused on global growth via new products, acquisitions and sales resource deployment. He began his career in sales with Baxter Healthcare. Following that, he spent 14 years with CR Bard, where he led the marketing department at Bard’s Davol division before being promoted to General Manager for Bard’s full portfolio in Asia-Pacific. Prior to joining Avanos, Tom was the Vice President of Venous Intervention at AngioDynamics.
Tom has a bachelor’s degree in communications from The University of North Carolina at Chapel Hill and a master’s degree in business administration from the University of Rhode Island.
A Global Footprint
5405 Windward Parkway
Alpharetta, Georgia 30004
Customer Service: 1 844 4Avanos
United Kingdom & Ireland
Avanos Medical UK Limited
Abbey House – 25 Clarendon Road – Redhill
Surrey RH1 1QZ
Ireland Customer Service
T. +32 2 700 68 51
F. +32 2 700 68 51
Avanos Medical Singapore Pte Ltd
101 Thomson Rd
SG 307591 Singapore
Customer Service: : +65 6350 4330
Avanos Medical Australia Pty Ltd
Suite 10.04, Level 10, Tower 1
475 Victoria Avenue
Chatswood NSW 2067
Customer Service: 1800 101 021
Avanos Medical India Private Limited
Kailash Business Park,
18th floor Unit 1803 of A Wing, HMPL Surya Nagar
Vikhroli West, Mumbai 400079
Avanos Medical (Shanghai) Co., Ltd.
Room 2358, Level 23
Five Corporate Avenue, No. 150 HuBin Road
HuangPu District, Shanghai, 200021